GlassScriptPhysician profile
Pramod Bhattarai
NPI 1235623232
$3,018.06
in general payments reported to CMS, 2019-2025
12 companies · $2,307 in 2025
The $2,307 reported for 2025 was more than what 88% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $21.32 · 2021: $113 · 2022: $121 · 2024: $456 · 2025: $2,307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,348 · Food and Beverage: $415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,347.64 |
| Food and Beverage | $415.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $2,400.90 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $138.60 | 2025 | Breztri, Fasenra |
| Glaxosmithkline, LLC. | $120.75 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $112.91 | 2021 | |
| Noah Medical Corporation | $79.18 | 2025 | Galaxy |
| Genzyme Corporation | $36.58 | 2025 | |
| Abbvie INC. | $32.13 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $21.32 | 2020 | |
| Amgen INC. | $20.71 | 2025 | Tezspire |
| Viatris Specialty LLC | $20.15 | 2025 | Yupelri |
| Verona Pharma, INC. | $18.38 | 2025 | Ohtuvayre |
| Phadia US INC. | $16.45 | 2025 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pramod Bhattarai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.